Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges

S Kar, P Devnath, TB Emran, TE Tallei… - Immunity …, 2022 - Wiley Online Library
Background The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and …

Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges

S Kar, P Devnath, TB Emran, TE Tallei… - Immunity …, 2022 - search.proquest.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and …

Oral and intranasal vaccines against SARS-CoV-2: Current progress, prospects, advantages, and challenges

S Kar, P Devnath, TB Emran… - Immunity …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and …

Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges.

S Kar, P Devnath, TB Emran, TE Tallei… - Immunity …, 2022 - search.ebscohost.com
Background: The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and …

[HTML][HTML] Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges

S Kar, P Devnath, TB Emran, TE Tallei… - Immunity …, 2022 - ncbi.nlm.nih.gov
Background The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and …

[PDF][PDF] Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges

S Kar, P Devnath, TB Emran, TE Tallei, S Mitra… - 2022 - scienceopen.com
Background: The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and …

Oral and intranasal vaccines against SARS-CoV-2: Current progress, prospects, advantages, and challenges.

S Kar, P Devnath, TB Emran, TE Tallei… - Immunity …, 2022 - europepmc.org
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and …

[PDF][PDF] Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges

S Kar, P Devnath, TB Emran, TE Tallei, S Mitra… - 2022 - researchgate.net
Background: The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has
caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and …

Oral and intranasal vaccines against SARS-CoV-2: Current progress, prospects, advantages, and challenges.

S Kar, P Devnath, TB Emran, TE Tallei… - Immunity …, 2022 - europepmc.org
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and …

Oral and intranasal vaccines against SARS-CoV-2: Current progress, prospects, advantages, and challenges

S Kar, P Devnath, TB Emran… - Immunity …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
caused a deadly pandemic in the 21st century, resulting in many deaths, economic loss, and …